The case involved a clinical trial of Akero's only product, a drug candidate aimed at treating a liver disease. It's the ...

Results support potential of efruxifermin (EFX) to reduce risk of fibrosis progression in patients with pre-cirrhotic (F2-F3) MASH ...

Equifax faces growth headwinds, premium valuation, and flat price action despite AI and cloud investments, with limited ...

Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of ...

Interactive Chart for Equifax Inc. (EFX), analyze all the data with a huge range of indicators.

Akero Therapeutics Announces Lancet Publication of the Phase 2b HARMONY Clinical Trial Demonstrating 96 Weeks Treatment with EFX Reduced Liver Fibrosis in Patients with Pre-cirrhotic MASH ...

Let's take a closer look.Everyone has their own methods for finding great value opportunities, but our model includes pairing an impressive grade in the Value category of our Style Scores system with ...